Vertex Pharmaceuticals Inc entered into an Agreement and Plan of Merger with Alpine Immune Sciences Inc, with Vertex commencing a cash tender offer to purchase all outstanding shares of common stock of Alpine Immune Sciences at a price of $65.00 per share.